The critical role of tech transfer and the value of strategic partnerships


In pharmaceutical manufacturing, tech transfer is the systematic transfer of knowledge, processes, and technologies from the development phase to commercial manufacturing and across production sites. This ensures that the scaling-up of drug production adheres to original product specifications and quality standards. A robust tech transfer protocol addresses risks associated with variations in production scales, such as differences in equipment and environmental factors. Additionally, tech transfer is vital for improving supply chain resilience, meeting regulatory compliance, and ensuring consistent product quality and safety for patients.

Strategic partnerships are integral to optimizing tech transfers by identifying and mitigating process risks. Collaborations between pharmaceutical companies and contract development and manufacturing organizations (CDMOs) foster an environment of shared expertise, resources, and capabilities. These partnerships provide access to cutting-edge technologies, specialized knowledge, and adaptable manufacturing facilities, all critical for efficient tech transfers. By leveraging the experience of a trusted CDMO partner, pharmaceutical companies can uphold project timelines, address common challenges, and achieve cost savings.

Download our article to explore these topics in detail, including tech transfer challenges for oral solid dosage (OSD), biological, and cell and gene therapy products. Additionally, learn about key partnership considerations for tech transfer success.

Technology transfer value